SAR448501/DR-0201
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SAR448501/DR-0201, covering 2025-12-23 to 2026-03-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases [Phase 1]